Baszler, T. V., Shkap, V., Mwangi, W., Davies, C. J., Mathison, B. A. and Mazuz, M. (2008). Bovine immune response to inoculation with Neospora caninum surface antigen SRS2 lipopeptides mimics immune response to infection with live parasites. Clinical and Vaccine Immunology 15, 659–667.
Bendtsen, J. D., Nielsen, H., Von-Heijne, G. and Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. Journal of Molecular Biology 340, 783–795.
Blake, D. P., Billington, K. J., Copestake, S. L., Oakes, R. D. and Quail, M. A. (2011). Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite. PLoS Pathology 7, e1001279
Cadwallader, K. A., Paterson, H., Macdonald, S. G. and Hancock, J. F. (1994). N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Molecular and Cellular Biology 14, 4722–4730.
Cannas, A., Naguleswaran, A., Muller, N., Eperon, S., Gottstein, B. and Hemphill, A. (2003). Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 126, 303–312.
Debache, K., Guionaud, C., Alaeddine, F., Mevissen, M. and Hemphill, A. (2008). Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. International Journal for Parasitology 38, 1455–1463.
Dubey, J. P. (1999). Neosporosis in cattle: biology and economic impact. Journal of the American Veterinary Medical Association 214, 1160–1163.
Dubey, J. P., Hanel, A. L., Lindsay, D. S. and Topper, M. J. (1988). Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. Journal of the American Veterinary Medical Association 193, 1259–1263.
Dubey, J. P. and Lindsay, D. S. (1996). A review of Neospora caninum and neosporosis. Veterinary Parasitology 67, 1–59.
Dubey, J. P., Schares, G. and Ortega-Mora, L. M. (2007). Epidemiology and control of neosporosis and Neospora caninum. Clinical Microbiology Reviews 20, 323–367.
Ellis, J., Miller, C., Quinn, H., Ryce, C. and Reichel, M. (2008). Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine 26, 5989–5996.
Haldorson, G. J., Stanton, J. B., Mathison, B. A., Suarez, C. E. and Baszler, T. V. (2006). Neospora caninum: Antibodies directed against tachyzoite surface protein NcSRS2 inhibit parasite attachment and invasion of placental trophoblasts in vitro. Experimental Parasitology 112, 72–178.
Hasler, B., Regula, G., Stark, K. D., Sager, H., Gottstein, B. and Reist, M. (2006 a). Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Preventive Veterinary Medicine 77, 230–253.
Hasler, B., Stark, K. D., Sager, H., Gottstein, B. and Reist, M. (2006 b). Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Preventive Veterinary Medicine 77, 254–283.
Hof, W. V. and Resh, M. D. (2000). Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation. Methods in Enzymology 327, 317–330.
Liao, M., Xuan, X. N., Huang, X., Shirafuji, H., Fukumoto, S., Hirata, H. and Fujisaki, K. (2005). Identification and characterization of cross-reactive antigens from Neospora caninum and Toxoplasma gondii. Parasitology 30, 481–488.
Martinez, A., Traverso, J. A., Valot, B., Ferro, M., Espagne, C. and Ephritikhine, G. (2008). Extent of N-terminal modifications in cytosolic proteins from eukaryotes. Proteomics 8, 2809–2831.
Maurer-Stroh, S., Eisenhaber, B. and Eisenhaber, F. (2002). N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences. Journal of Molecular Biology 317, 523–540.
Monney, T., Debache, K. and Hemphill, A. (2011). Vaccines against a major cause of abortion in cattle, Neospora caninum infection. Animals 1, 306–325.
Nishikawa, Y., Xuan, X., Nagasawa, H., Igarashi, I., Fujisaki, K. and Otsuka, H. (2000). Monoclonal antibody inhibition of Neospora caninum tachyzoite invasion into host cells. International Journal for Parasitology 30, 51–58.
Nishikawa, Y., Xuan, X., Nagasawa, H., Igarashi, I., Fujisaki, K. and Otsuka, H. (2001). Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19, 1710–1716.
Nishikawa, Y., Zhang, H. S., Ikehara, Y., Kojima, N., Xuan, X. N. and Yokoyama, N. (2009). Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice. Clinical and Vaccine Immunology 16, 792–797.
Peitzsch, R. M. and McLaughlin, S. (1993). Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry 32, 10436–10443.
Pinitkiatisakul, S., Friedman, M., Wikman, M., Mattsson, J. G. and Lundén, A. (2007). Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine 25, 3658–3668.
Podell, S. and Gribskov, M. (2004). Predicting N-terminal myristoylation sites in plant proteins. BMC Genomics 5, 37.
Ren, J., Wen, L. P., Gao, X. J., Jin, C. J., Xue, Y. and Yao, X. B. (2008). CSS-Palm 2.0: an updated software for palmitoylation sites prediction. Protein Engineering, Design and Selection 21, 639–644.
Resh, M. D. (1999). Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochimica et Biophysica Acta 1451, 1–16.
Sibley, L. D., Messina, M. and Niesman, I. R. (1994). Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proceedings of the Nationall Academy of Sciences, USA 91, 5508–5512.
Zha, J., Weiler, S., Oh, K. J., Wei, M. C. and Korsmeyer, S. J. (2000). Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290, 1761–1765.
Zhang, G. H., Huang, X. H., Boldbaatara, D., Battura, B., Battsetsega, B. and Zhang, H. S. (2010). Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Vaccine 28, 7243–7247.
Zhang, H. S., Compaore, M. K. A., Lee, E., Liao, M., Zhang, G. H. and Xuan, X. X. (2007 a). Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites. Molecular and Biochemical Parasitology 151, 205–212.
Zhang, H. S., Lee, E., Liao, M., Compaore, M. K. A., Zhang, G. H. and Kawase, O. (2007 b). Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis. Molecular and Biochemical Parasitology 153, 141–148.
Zhou, F., Xue, Y., Yao, X. and Xu, Y. (2006). CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics 22, 894–896.